About Retrosynthesis & Synthesis Planning
Retrosynthesis & Synthesis Planning software addresses a specific bottleneck in early drug discovery: deciding whether a proposed molecule can actually be made, by what route, and at what cost in time and reagents. Medicinal chemists and computational chemists use these tools to score synthesisability before committing bench resources, to generate ranked route options for novel scaffolds, and to identify commercially available starting materials. The category sits under constant tension between coverage of published reaction space, the proprietary nature of in-house synthetic know-how, and the integration demands of electronic lab notebooks, inventory systems, and generative design pipelines that feed candidates downstream.
Two patterns stand out in this category. Every tool in the directory incorporates machine learning, reflecting how thoroughly transformer and graph-based models have displaced rule-only expert systems for disconnection prediction. Deployment is also heavily skewed toward on-premise installation, with roughly 90% offered that way and only a small share available as managed cloud. That distribution tracks the IP sensitivity of target structures and internal reaction history — pharma and biotech buyers are generally unwilling to route confidential chemistry through external infrastructure, and academic groups often want local control over training data and model behaviour.
Browse Retrosynthesis Software
Retrosynthesis planning and molecular property prediction using expert-curated AI rules and physical organic heuristics for drug discovery.
Machine learning-guided reaction optimization that learns from experimental data to identify optimal conditions in fewer rounds with less material waste.
AI-powered retrosynthesis and synthetic pathway discovery with impurity prediction, synthesizability assessment, and process chemistry optimization.
AI-driven reaction condition optimization that systematically ranks feasible conditions, flags safety risks, and suggests solutions for efficient synthesis design.
Generate large-scale molecular libraries with synthesizable candidates by optimizing core structures and synthetic routes.
AI-powered prediction of impurity structures and formation pathways in chemical reactions with >90% accuracy.
AI-driven synthetic route optimization, reaction condition suggestions, and scale-up strategies for efficient pharmaceutical and chemical synthesis.
AI-driven retrosynthesis design generating feasible synthetic routes with machine learning and chemical intuition for novel and existing molecules.
AI-driven synthesizability assessment evaluating reaction complexity, building block availability, and cost to prioritize accessible compounds.
AI-driven retrosynthesis planning that transforms target compounds into commercially available starting materials in seconds.
Common Questions About Retrosynthesis & Synthesis Planning
Other subdomains within Drug Discovery & Molecular Design
Cheminformatics & Compound Management
Software for chemical drawing, compound library management, substructure and similarity search, SAR analysis, and small molecule preparation for drug design workflows.
Generative Molecular & Biologics Design
AI and generative models that de novo design or optimise small molecules, peptides, antibodies, proteins, and biologics with desired therapeutic properties -- potency, selectivity, ADMET, and synthesisability.
Molecular Docking & Virtual Screening
Tools predicting ligand-receptor binding and enabling large-scale virtual screening using structure-based, ligand-based, or shape-based methods to identify drug candidates.
Molecular Modeling & Simulation
Physics-based platforms for protein structure prediction, homology modeling, molecular dynamics, binding free energy calculation, and 3D visualisation.
Quantum & Physics-Enhanced Drug Design
Tools applying quantum mechanical calculations or hybrid quantum-AI methods to improve accuracy in binding affinity prediction and lead optimisation.
Companies with the largest Retrosynthesis software portfolios
Chemical.AI
- AI-driven retrosynthesis and synthesis planning for pharmaceutical, biotech, and CRO researchers, including synthesizability assessment and impurity prediction.
Iktos
- Generative AI and robotics for accelerated small-molecule drug discovery, from design through preclinical candidate in under 24 months.
SciY
- Instrument integration, data standardization, and AI-readiness for research, development, and manufacturing across biopharmaceuticals, materials science, and clinical labs.